Omeros (OMER) – Trading Halts
-
Omeros (OMER) says narsoplimab did not achieve statistically significant improvement over placebo in Phase 3 trial
-
Omeros (OMER) Halted, News Pending
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to OMER Stock Lookup